51吃瓜黑料曝料

Dr. Vaibhav is the director of Brain Injury, Senescence, and Translational Neuroscience Lab in the Department of Neurosurgery. As an Assistant Professor in the Department of Neurosurgery, Kumar Vaibhav has secured continuous extramural funding since 2017, focusing on high-impact research in Neuroscience, particularly in Traumatic Brain Injury (TBI). His lab's pioneering work on cannabinoid receptors in brain macrophages has established him as a leader in this field.

Since his promotion in 2020, he has significantly advanced understanding of immune responses post-trauma. Despite COVID-19 challenges, his achievements include securing multiple grants, publishing 72 peer-reviewed articles (Over 4500 citations with h index 34 in Nov. 2024), delivering numerous invited talks, and chairing symposiums. He actively mentors students, contributing to their success in research. Vaibhav is committed to professional development and has received notable awards for his contributions to science.

Dr. Vaibhav's research is primarily centered on understanding the mechanisms underlying neurovascular injuries and the immune response in the nervous system. His work is particularly relevant to conditions such as stroke, traumatic brain injury, and neurodegenerative diseases, where both neuronal damage and inflammatory responses play critical roles. . His work is characterized by a rigorous experimental approach, often involving in vitro and in vivo models to study neurovascular and neuroimmune interactions. His research findings have implications for developing new therapeutic strategies to treat various neurological disorders. By identifying the molecular targets involved in neurovascular injuries and the immune response, Dr. Vaibhav's work paves the way for potential interventions that could enhance recovery and improve patient outcomes.

Neurovascular Injury:

 Dr. Vaibhav investigates the cellular and molecular mechanisms that contribute to neurovascular injury after TBI and hemorrhages. This includes studying the Neuroinflammation, blood-brain barrier's integrity and how it is compromised during pathological conditions. His research aims to identify potential therapeutic targets that could mitigate or prevent injury, thereby improving outcomes for patients suffering from cerebrovascular disorders.

TBI & Neurodegeneration:

One of the focus area of research in the lab is to explore chronic pathology post-TBI and TBI-associated neurodegeneration. The lab is actively exploring the cerebral atrophy, behavioral deficits and immunosenescence in chronic period.

Neuroimmunology:

   Another significant aspect of Dr. Vaibhav's research is neuroimmunology, which examines the interactions between the nervous system and the immune system. He explores how immune responses can exacerbate or ameliorate neuronal injury. By understanding these interactions, Dr. Vaibhav aims to develop strategies that could harness the immune system to promote neuronal repair and recovery following injury.

Hypoxia & Hypoglycemia:

   His earlier studies on hypoxia and hypoglycemia have provided insights into how these conditions lead to neuronal injury. Dr. Vaibhav's research has shown that the brain's response to low oxygen and glucose levels can trigger a cascade of neurodegenerative processes. By elucidating these pathways, he seeks to identify novel neuroprotective strategies that could be employed in clinical settings.

Stroke & Neuropharmacology:

   Dr. Vaibhav's Ph.D. work focused on stroke and neuropharmacology, where he investigated the pharmacological agents that could potentially protect neurons from ischemic damage. His findings contribute to the broader understanding of how certain drugs can modulate neuroinflammation and promote neuronal survival during and after a stroke.

• Kumar Vaibhav鈥檚 profile

/faculty/directory/view.php?id=KVAIBHAV

Eurekalert!AAAS:

• CBD and Alzheimer鈥檚 disease

Jagwire (March 8, 2021)

Mentioned my name as a co-author of study.

• Cannabinoids may help limit secondary damage of TBIs.

The Nation (May 19, 2021):

Ideahunter Science (May 17, 2021):

JagWire (Nov 17, 2020):

Eurelkalert!AAAS (Nov 17, 2020): 

NRTimes (Nov 19, 2020):

Cannabishealth (Nov 19, 2020):

Grantome:

• Emerging scientist Award: Emerging Science Award - 2020

European Higher Education Organization (Jan 14, 2021): https://eurohighereducation.com/2021/01/14/faculty-recognized-with-augusta-university-research-institute-awards/

• TRPV1 in TBI (Receptor that feels the heat of a red chili pepper may be target for TBI recovery):

MedicalXpress (Apr 13, 2018):

JagWire (Apr 13, 2018):  

Medical news (Apr 13, 2018):

• CBD may help avert lung destruction in COVID-19

WHO (COVID-19, Global literature on coronavirus disease, Article | WHO COVID | ID: covidwho-638503)

Jagwire (July 16, 2020)     (Mentioned my name as a co-author of study)

Research Article published (July 8, 2020)

• Dean鈥檚 Diary-Dr. Kumar Vaibhav and his R01 grant (Aug 21, 2020)

• Stem cells therapy in stroke:

Science daily/UGA (Feb 15, 2018):

Mentioned my name as a co-author of study in reference section.

• Cannabinoids & brain:

Meta fact (May 28, 2018):